leisure time -WSS

leisure time

author：comprehensive 2025-10-02 10:28:47 - browse：3

A syringe injects into a segment of DNA — biotech coverage from STAT — Adobe

Two congenitally deaf children can hear for the first time after being treated with gene therapy, according to data presented at a conference Wednesday.

The results are “jaw-droppingly good, just shocking how good. It exceeded the wildest expectations of anybody who started this work,” said Larry Lustig, an otolaryngologist at Columbia University and an investigator on the study.

The new data come from a larger study by Regeneron Pharmaceuticals that will treat nearly two dozen children with a specific type of congenital hearing loss with gene therapy. The clinical trial is meant to measure safety and efficacy of DB-OTO, a gene therapy drug Regeneron is developing to treat children who have hearing loss due to changes in the otoferlin gene. Several teams are targeting this rare form of congenital deafness that affects 1% to 8% of deaf people globally, including a team with Akouos, an Eli Lilly subsidiary, which successfully treated an 11-year-old boy with a similar gene therapy. Lustig calls this the “lowest of the low-hanging fruit” for gene therapy deafness treatments.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Continuity nursing helped my family in our darkest PICU moments
Next article： DOJ, FTC to increase scrutiny of all types of health care mergers

WSS

Medical experts are missing from AI regulatory conversations

Readout LOUD podcast: A CRISPR milestone, biotech mixology

Weight loss drug costs may need more research, senator suggests

Lindsay Lohan welcomes 1st child with husband Bader Shammas

New warning issued for rebooking air travel after delays, cancellations

Readout Newsletter: Bayer's future, Merck Caraway acquisition, etc

explore

leisure time

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

Wikipedia

New air purifier tech could be key to improving indoor air quality

Hospitals look to new technology to keep health care workers safe

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Readout Newsletter: What is Casgevy? Does Wegovy hurt muscle?

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Readout Newsletter: The latest at Gilead, Catalent, and the NIH

Alkermes shareholders re

Why medical students are struggling with mental health

What does generative AI mean for health care? We asked experts

NYU radiologists take on the challenge of expensive MRI machines

hotspot

No Labels group has 'steep climb,' but third party 'worth trying': Larry Hogan

Ebola public health emergency is over, WHO declares

Childhood cancer progress stalls for Black, Hispanic kids: Report

Hospitals look to new technology to keep health care workers safe

Couple fighting to bring baby home from Mexico are finally reunited

Readout Newsletter: What is Casgevy? Does Wegovy hurt muscle?

focus

Wikipedia

knowledge

focus